Andrew Tak Shing Lo
Known title: Senior Managing DirectorCIK: 0001407922
Associated companies
Transaction History
| IVZ | ▼ Sell | Open Market | 100,840 | $3.2M | 9/9/2026 | View on chart |
| IVZ | ▼ Sell | Open Market | 42,530 | $1.4M | 9/8/2026 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 116,754 | $0 | 7/2/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 16,479 | $0 | 2/28/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 83,419 | $0 | 2/28/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 14,333 | $0 | 2/28/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 17,923 | $0 | 2/28/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 18,113 | $0 | 2/28/2026 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 13,122 | $0 | 2/28/2025 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 16,478 | $0 | 2/28/2025 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 16,807 | $0 | 2/28/2025 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 14,333 | $0 | 2/28/2025 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 17,923 | $0 | 2/28/2025 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 13,122 | $0 | 2/28/2024 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 16,478 | $0 | 2/28/2024 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 25,538 | $0 | 2/28/2024 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 51,962 | $0 | 2/28/2024 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 14,333 | $0 | 2/28/2024 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 17,631 | $0 | 2/28/2023 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 25,537 | $0 | 2/28/2023 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 70,585 | $0 | 2/28/2023 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 13,122 | $0 | 2/28/2023 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 16,478 | $0 | 2/28/2023 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 10,099 | $0 | 2/28/2022 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 17,630 | $0 | 2/28/2022 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 53,384 | $0 | 2/28/2022 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 25,538 | $0 | 2/28/2022 | View on chart |
| IVZ | ▲ Buy | Option Exercise | 13,121 | $0 | 2/28/2022 | View on chart |
| IVZ | ▼ Sell | Open Market | 150,000 | $3.7M | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Invesco to Report Q3 2026 Results; Dividends Declared
Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.
Invesco to Report Q3 2026 Results; Dividends Declared. Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.